Clinical Child Psychology and Psychiatry

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bramble, D. J.
Right arrow Articles by Cosgrove, P. V.F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bramble, D. J.
Right arrow Articles by Cosgrove, P. V.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Child Psychology and Psychiatry, Vol. 7, No. 2, 225-233 (2002)
DOI: 10.1177/1359104502007002009

Parental Assessments of the Efficacy of Risperidone in Attention Deficit Hyperactivity Disorder

D. J. Bramble

Moore House CAMHS, Lincoln, UK

P. V.F. Cosgrove

The Bristol Priority Clinic, Bath, UK

A postal survey was undertaken of the parents of 326 patients with severe and complex forms of attention deficit hyperactivity disorder (ADHD) to obtain their views of the efficacy and safety of risperidone augmentation therapy. Replies were received from parents of 170 patients (mean age: 14.3; SD: 4.4; range: 4–27 years). The results revealed an overall symptomatic improvement resulting from the risperidone therapy: 92% of parents and 100% of the prescribing clinician’s ratings indicated a net benefit of treatment (on a visual analogue rating scale); a good adherence rate (81%); low rates of significant adverse effects (8%); and a reduction of reported offending rates (overall 93% reduction comparing rates before and during risperidone therapy in 30 patients). Furthermore, most parents feared that their offspring would become ‘uncontrollably aggressive’ (84%) and ‘un- manageable’ (74%) should the risperidone therapy be stopped abruptly. It is concluded that risperidone augmentation appears to represent a well-tolerated and effective means of helping children and young adults with complex and severe forms of ADHD. However, its ‘off-label’ use in this context requires a high level of clinical caution at present.

Key Words: ADHD • augmentation therapy • children • offending behaviour • risperidone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?